Dachaigh › Dermatitis Atopach (Eczema) › Texas

Sgrùdaidhean clionaigeach Dermatitis Atopach (Eczema) ann an Texas

Tha 18 sgrùdaidhean airson Dermatitis Atopach (Eczema) a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Clinical Site 102, College Station
Clinical Site 104, San Antonio

A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain

Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07453602

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Reveal Research Institute - Dallas- Site Number : 8400012, Dallas
Austin Institute for Clinical Research, Inc- Site Number : 8400030, Pflugerville
Complete Dermatology - Sugar Land- Site Number : 8400001, Sugar Land

A’ fastadhSgrùdadh amharc

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Arlington
Novartis Investigative Site, Cypress
Novartis Investigative Site, Dallas
agus 2 a bharrachd

A’ fastadhÌre 2

Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Arlington
Enveda Investigative Site, Houston
Enveda Investigative Site, San Antonio

A’ fastadhÌre 2

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07298395

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

Texas Dermatology and Laser Specialists, San Antonio

A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain

Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07527923

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Texas Dermatology and Laser Specialists, San Antonio

A’ fastadhÌre 3

Aoisean 2 gu 11 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06807281

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Dallas
Investigational Site, Frisco
Investigational Site, San Antonio

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07003425

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

Harrison Dermatology, Missouri City

A’ fastadhSgrùdadh amharc

Aoisean 12 gu 89 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07645820

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

ALS Global, Irving

A’ fastadhÌre 2/3

Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07355075

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Progressive Clinical Research, PA, San Antonio

A’ fastadhÌre 2

Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 8, Southlake

A’ fastadhÌre 2

Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Dallas
Enveda Investigative Site, San Antonio
Enveda Investigative Site, Sugar Land

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07643766

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Arlington Research Center, Inc /ID# 266330, Arlington
3A Research - East location /ID# 267622, El Paso
Prime Clinical Research - Mansfield - East Broad Street /ID# 268042, Mansfield
agus 2 a bharrachd

A’ fastadhÌre 3

Aoisean 2 gu 11 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06461897

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Arlington Research Center, Inc /ID# 263665, Arlington
Studies in Dermatology LLC /ID# 263335, Cypress
Dermatology Treatment and Research Center /ID# 265812, Dallas
agus 6 a bharrachd

A’ fastadhÌre 3

Aoisean 18 gu 63 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT06389136

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

UT Health Science Houston, Bellaire
Center for Clinical Studies, Webster

A’ fastadhÌre 2

Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT06397911

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Dermatology Treatment and Research Center, Dallas
North Texas Center for Clinical Research, Frisco
DCT-Stone Oak, LLC dba Discovery Clinical Trials, San Antonio
agus 1 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Cèit 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site 7082, Cedar Park
Galderma Investigational Site 8238, Dallas
Galderma Investigational Site 7062, Edinburg
agus 3 a bharrachd

A’ fastadhSgrùdadh amharc

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT06988605

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Clinical Investigations of Texas, Dallas

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Dùbh 2025 · NCT06982352

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.